Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kingston Technologies appears to have been a historical U.S. medical device company rather than a biotech or pharmaceutical developer. Publicly visible evidence points to products in wound care and specialty devices, including FDA-cleared wound dressings and older ophthalmic and urology-related devices such as intraocular lenses and ureteral stents. The company also held patents related to hydrogel-coated guidewires and other device technologies. Available sources are sparse and largely historical, and there is no clear evidence of a current operating biotech, pharma, or broader life sciences company using this exact name today. Based on the accessible record, Kingston Technologies is best characterized as a legacy medical device company with limited currently available corporate information.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kingston Technologies.